Nebenwirkungen · Voxzogo
Voxzogo 0.4 mg powder and solvent for solution for injection Voxzogo 0.56 mg powder and solvent for solution for injection Voxzogo 1.2 mg powder and solvent for solution for injection · Abschnitt 4.8 · PDF-Seite 5
HOS-147653 · Präparat HOS-099710
Adverse reactions are listed below by MedDRA system organ class and by frequency. Frequencies are defined as very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1 000 to < 1/100); rare (≥ 1/10 000 to < 1/1 000); very rare (< 1/10 000); not known (cannot be estimated from available data). Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-08-13T16:29:00Z · SHA-256 fb643ae4efb98635a53d56c9c158837df12bb2bd2fc703e8d0c1eed970a20049 · Passage 48049931efebea3a62bd962c54a9522257fec7557877ba1382050cee7334ba16 · Zeichen 282–682 im Abschnitt